Withers & Rogers Llp opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Withers & Rogers Llp

Patent Number:
Title:
Charged Depth Filtration Of Antigen-Binding Proteins
Applicant:
Opposition Date:
Jun 26, 2024
Patent Number:
Title:
Enhancing The Effect Of Car-Engineered T Cells By Means Of Nucleic Acid Vaccination
Opposition Date:
Apr 25, 2024
Patent Number:
Title:
Individualized Vaccines For Cancer
Applicant:
Opposition Date:
Jan 25, 2024
Patent Number:
Title:
System And Method For Targeted Depletion Of Nucleic Acids
Opposition Date:
Jan 4, 2024
Patent Number:
Title:
Process For Lyophilized Pharmaceutical Formulation Of A Therapeutic Protein
Applicant:
Opposition Date:
Feb 20, 2023
Patent Number:
Title:
Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses Thereof
Applicant:
Opposition Date:
Feb 17, 2023
Patent Number:
Title:
Respiratory Virus Vaccines
Applicant:
Opposition Date:
Jan 26, 2023
Patent Number:
Title:
Modified Nucleoside, Nucleotide, And Nucleic Acid Compositions
Opposition Date:
Dec 2, 2022
Patent Number:
Title:
Terminally Modified Rna
Opposition Date:
Nov 23, 2022
Patent Number:
Title:
Site-Specific Bio-Conjugation Methods And Compositions Useful For Nanopore Systems
Opposition Date:
Nov 21, 2022

Want to track Withers & Rogers Llp?

Feel free to send us a message here and we will get back to you